Boston Scientific Corp Stock Today

BSX Stock  USD 67.24  1.01  1.52%   

Performance

22 of 100

 
Low
 
High
Solid

Odds Of Distress

Less than 1

 
100  
 
Zero
Very Small
Boston Scientific is trading at 67.24 as of the 18th of March 2024; that is 1.52% increase since the beginning of the trading day. The stock's open price was 66.23. Boston Scientific has a very small chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Equity ratings for Boston Scientific Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of March 2022 and ending today, the 18th of March 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
18th of May 1992
Category
Healthcare
Classification
Health Care
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. Boston Scientific operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 1.47 B outstanding shares of which 9.44 M shares are currently shorted by investors with about 1.37 days to cover. More on Boston Scientific Corp

Moving together with Boston Stock

  0.73FEMY Femasys Earnings Call This WeekPairCorr
  0.66AHG Akso Health GroupPairCorr
  0.71CAH Cardinal Health Financial Report 2nd of May 2024 PairCorr

Moving against Boston Stock

  0.8FIGS Figs Inc Financial Report 2nd of May 2024 PairCorr
  0.76NEOG Neogen Report 4th of April 2024 PairCorr
  0.71CMAXW CareMaxPairCorr
  0.65SSY SunLink Health SystemsPairCorr
  0.64MASS 908 Devices Financial Report 14th of May 2024 PairCorr
  0.59DYNT Dynatronics Financial Report 9th of May 2024 PairCorr
  0.53TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr

Boston Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Boston Scientific's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Boston Scientific or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Boston Scientific's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Boston Scientific's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
ChairmanMichael Mahoney
Thematic Ideas
(View all Themes)
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, Medical Equipment, Healthcare, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal Testing
Average Analyst Recommendation
Analysts covering Boston Scientific report their recommendations after researching Boston Scientific's financial statements, talking to executives and customers, or listening in on Boston Scientific's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Boston Scientific Corp. The Boston consensus assessment is calculated by taking the average forecast from all of the analysts covering Boston Scientific.
Financial Strength
Based on the measurements of operating efficiency obtained from Boston Scientific's historical financial statements, Boston Scientific Corp is performing exceptionally good at this time. It has a great probability to report excellent financial results in April. Financial strength of Boston Scientific Corp is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.670.4053
Way Up
Slightly volatile
Gross Profit Margin0.770.6949
Significantly Up
Slightly volatile
Net Debt9.1 B8.6 B
Sufficiently Up
Slightly volatile
Total Current Liabilities5.2 B4.9 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total6.2 B10.7 B
Way Down
Slightly volatile
Total Assets36.9 B35.1 B
Sufficiently Up
Slightly volatile
Total Current Assets3.3 B6.5 B
Way Down
Slightly volatile
Total Cash From Operating Activities2.6 B2.5 B
Sufficiently Up
Slightly volatile
Boston Scientific's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Boston Scientific's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Boston Scientific's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Boston Scientific's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Boston Scientific's financial leverage. It provides some insight into what part of Boston Scientific's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Boston Scientific's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Boston Scientific deploys its capital and how much of that capital is borrowed.
Liquidity
Boston Scientific cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 9.49 B in debt with debt to equity (D/E) ratio of 0.51, which is OK given its current industry classification. Boston Scientific Corp has a current ratio of 1.42, which is typical for the industry and considered as normal. Debt can assist Boston Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Boston Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Boston Scientific Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Boston to invest in growth at high rates of return. When we think about Boston Scientific's use of debt, we should always consider it together with cash and equity.

Net Income

1.67 Billion
Boston Scientific Corp (BSX) is traded on New York Stock Exchange in USA. It is located in 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 and employs 48,000 people. Boston Scientific is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 97.17 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Boston Scientific's market, we take the total number of its shares issued and multiply it by Boston Scientific's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Boston Scientific Corp runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 1.47 B outstanding shares of which 9.44 M shares are currently shorted by investors with about 1.37 days to cover. Boston Scientific Corp has about 928 M in cash with 2.5 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.24.
Check Boston Scientific Probability Of Bankruptcy
Ownership Allocation
Boston Scientific Corp retains a total of 1.47 Billion outstanding shares. The majority of Boston Scientific Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Boston Scientific Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Boston Scientific. Please pay attention to any change in the institutional holdings of Boston Scientific Corp as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Boston Ownership Details

Boston Stock Price Odds Analysis

Based on a normal probability distribution, the odds of Boston Scientific jumping above the current price in 90 days from now is about 11.42%. The Boston Scientific Corp probability density function shows the probability of Boston Scientific stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Boston Scientific has a beta of 0.3255 suggesting as returns on the market go up, Boston Scientific average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Boston Scientific Corp will be expected to be much smaller as well. Additionally, the company has an alpha of 0.2267, implying that it can generate a 0.23 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 67.24HorizonTargetOdds Above 67.24
88.49%90 days
 67.24 
11.42%
Based on a normal probability distribution, the odds of Boston Scientific to move above the current price in 90 days from now is about 11.42 (This Boston Scientific Corp probability density function shows the probability of Boston Stock to fall within a particular range of prices over 90 days) .

Boston Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Boston Scientific that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Boston Scientific's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Boston Scientific's value.
InstituionRecorded OnShares
Bollard Group Llc2023-12-31
22.4 M
Citadel Advisors Llc2023-09-30
21.2 M
Dz Bank Ag Deutsche Zentral-genossenschaftsbank Frankfurt Am Main2023-12-31
21.1 M
Hhg Plc2023-12-31
19.5 M
Morgan Stanley - Brokerage Accounts2023-12-31
18.8 M
Artisan Partners Limited Partnership2023-12-31
17.2 M
Bank Of New York Mellon Corp2023-12-31
17 M
Norges Bank2023-12-31
16.1 M
Northern Trust Corp2023-12-31
13.7 M
Fmr Inc2023-12-31
138.3 M
Blackrock Inc2023-12-31
126.6 M
View Boston Scientific Diagnostics

Boston Scientific Historical Income Statement

Boston Scientific Corp Income Statement is one of the three primary financial statements used for reporting Boston's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Boston Scientific Corp revenue and expense. Boston Scientific Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Boston Scientific's Income Before Tax is fairly stable compared to the past year. Net Income is likely to rise to about 1.7 B in 2024, whereas Interest Expense is likely to drop slightly above 193.9 M in 2024. View More Fundamentals

Boston Stock Against Markets

Picking the right benchmark for Boston Scientific stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Boston Scientific stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Boston Scientific is critical whether you are bullish or bearish towards Boston Scientific Corp at a given time. Please also check how Boston Scientific's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Boston Scientific without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Investing Opportunities Now

   

Investing Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module

Boston Scientific Corporate Directors

Boston Scientific corporate directors refer to members of a Boston Scientific board of directors. The board of directors generally takes responsibility for the Boston Scientific's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Boston Scientific's board members must vote for the resolution. The Boston Scientific board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Edward LudwigLead Independent DirectorProfile
Donna JamesIndependent DirectorProfile
Stephen MacMillanIndependent DirectorProfile
Ellen ZaneIndependent DirectorProfile

How to buy Boston Stock?

Before investing in Boston Scientific, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Boston Scientific. To buy Boston Scientific stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Boston Scientific. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Boston Scientific stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Boston Scientific Corp stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Boston Scientific Corp stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Boston Scientific Corp, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Boston Stock please use our How to Invest in Boston Scientific guide.

Already Invested in Boston Scientific Corp?

The danger of trading Boston Scientific Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Boston Scientific is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Boston Scientific. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Boston Scientific Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Boston Scientific Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Boston Scientific's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Boston Scientific Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Boston Scientific Corp Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Boston Stock analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.856
Earnings Share
1.07
Revenue Per Share
9.8
Quarterly Revenue Growth
0.149
Return On Assets
0.0447
The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.